News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3125last 7d

511● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1819 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: BMYsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

The Wall Street Journal94d agoneutral

Deal or No Deal, AstraZeneca Stock Is a Bargain

BMY PFE

Pharma Voice94d agoneutral

What the AstraZeneca-BMS rumors reveal about pharma megamergers

BMY

MarketBeat94d agoneutral

Schrodinger Q2 Earnings Call Highlights

BMY SDGR

BioPharma Dive95d agoneutral

Cardiac drug developer Braveheart banks more than $382M in IPO

BMY

The Wall Street Journal95d agoneutral

💬 Money Quote: Novo Nordisk CEO

BMY NVO

Stocktwits95d agoneutral

AstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks - ‘There Never Was A Deal To Be Done’

BMY

Reuters95d agoneutral

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

BMY

Quartz95d agoneutral

AstraZeneca and Bristol Myers Squibb merger talks denied

BMY

The Wall Street Journal95d agoneutral

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

BMY NVO

TheStreet96d agoneutral

AstraZeneca-BMY megadeal talk sparks huge market rift

BMY

Proactive96d agoneutral

Brokers split on AstraZeneca merger talk as shares recover some ground

BMY

MarketBeat96d agoneutral

BioNTech Q2 Earnings Call Highlights

BMY

Barrons.com96d agoneutral

AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open

ABBV BMY LLY PFE

Axios96d agoneutral

How a pharma megamerger could squelch R&D

BMY

Motley Fool97d agoneutral

Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript

BMY

Moby97d agoneutral

AstraZeneca Eyes a Pharma Megamerger Nobody Asked For

BMY

Bloomberg97d agoneutralVIDEO

AstraZeneca Investors See Little Logic in Bristol Tie-Up

BMY

PA Media: Money97d agoneutral

Stocks mixed as AstraZeneca merger talk dents FTSE 100

ABBV BMY JNJ LLY

Investing.com97d agoneutral

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?

BMY

MT Newswires97d agoneutral

European Stocks Close Mostly Higher in Monday Trading; AstraZeneca Reportedly in Merger Talks With Bristol Myers

BMY

Zacks97d agoneutral

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

BIIB BMY JNJ

Investor's Business Daily97d agoneutral

AstraZeneca Stock Nosedives On Mega-Merger Rumor

BMY

Quartz97d agoneutral

AstraZeneca, Bristol Myers Squibb exploring merger talks

BMY

MT Newswires97d agoneutral

Stocks Rise Pre-Bell as Trump Calls Off Planned Iran Strikes; Labor Market Data, Corporate Earnings on Deck

AMD BMY CAT DIS LLY MCD MRK PLTR+6

TheStreet97d agoneutral

Morgan Stanley uncovers major Bristol Myers stock signals

BMY MS

The Wall Street Journal97d agoneutral

Health Care Roundup: Market Talk

BMY

Reuters97d agoneutral

Wall St futures edge up on Mideast deal hopes; healthcare in focus

BMY

Simply Wall St.97d agoneutral

Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca

BMY

PA Media: Money97d agoneutral

AstraZeneca in talks over £300bn mega-merger with US rival - reports

BMY

Reuters98d agoneutral

AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

BMY